RECURRENT PROSTATE CANCER
Clinical trials for RECURRENT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for RECURRENT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a special diet make chemotherapy easier and more effective?
Disease control OngoingThis study is testing whether eating a special, low-calorie diet before and during chemotherapy can help reduce side effects and make the treatment work better. It involves 130 people with breast cancer or prostate cancer who are receiving specific chemotherapy drugs. Participant…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: NA • Sponsor: University of Southern California • Aim: Disease control
Last updated Apr 01, 2026 18:25 UTC
-
Short, sharp blast of radiation aims to zap returning prostate cancer
Disease control OngoingThis study is testing a new, shorter radiation treatment for men whose prostate cancer has come back in the area where the prostate was removed. The treatment involves just five high-dose radiation sessions, combined with six months of hormone-blocking drugs. Researchers want to …
Matched conditions: RECURRENT PROSTATE CANCER
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Precision radiation tested to stop prostate Cancer's return
Disease control OngoingThis early-stage study is testing whether higher doses of very precise radiation can safely treat prostate cancer that returns after surgery. Researchers are carefully increasing the radiation dose for 26 patients who have had their prostate removed to find the highest amount tha…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New radiation combo tested for prostate cancer safety
Disease control OngoingThis study aims to determine if combining two targeted radiation treatments is safe for men with intermediate-risk prostate cancer. The approach involves a brief internal radiation treatment followed by a shorter, more precise external radiation course over three weeks. Researche…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC
-
Triple-Threat attack on prostate cancer shows promise
Disease control OngoingThis early-stage trial is testing whether combining three different treatments is safe for men with aggressive prostate cancer. The approach uses a hormone-blocking drug (enzalutamide), radiation therapy, and standard hormone injections to attack the cancer from multiple angles. …
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Feb 27, 2026 15:05 UTC